Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.030
+0.032 (3.17%)
At close: Sep 17, 2026, 4:00 PM EDT
1.040
+0.010 (0.97%)
After-hours: Sep 17, 2026, 7:57 PM EDT
Ocugen Market Cap
Ocugen has a market cap or net worth of $349.28 million as of September 17, 2026. Its market cap has decreased by -4.41% in one year.
Market Cap
349.28M
Enterprise Value
337.22M
1-Year Change
-4.41%
Ranking
Category
Stock Price
$1.03
ChartMarket Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $349.28M, an increase of 966.54%. That is a compound annual growth rate of 40.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 349.28M | -17.16% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evommune | 362.56M |
| X4 Pharmaceuticals | 358.91M |
| Century Therapeutics | 358.53M |
| Enanta Pharmaceuticals | 357.95M |
| DiaMedica Therapeutics | 352.13M |
| Palisade Bio | 351.16M |
| Lexeo Therapeutics | 338.84M |
| Compass Therapeutics | 333.16M |